Catheter Precision holder discloses 9.79% stake
Catheter Precision, Inc. received a Schedule 13G reporting that SEG JETS SPV I, LLC, a Delaware limited liability company, is a significant shareholder.
Rhea-AI Filing Summary
Catheter Precision, Inc. received a Schedule 13G reporting that SEG JETS SPV I, LLC, a Delaware limited liability company, is a significant shareholder. SEG JETS SPV I, LLC reports beneficial ownership of 1,065,620 shares of common stock, with shared voting and dispositive power over all of these shares and no sole power.
This position represents 9.79% of Catheter Precision’s common stock, based on 10,880,868 shares outstanding as verified with the issuer on July 17, 2026. The filing is signed by Joseph Reda, as Manager of SEG JETS SPV I, LLC.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Catheter Precision, Inc. (VTAK) does SEG JETS SPV I, LLC report?
How was SEG JETS SPV I, LLC’s 9.79% ownership in VTAK calculated?
Who signed the Schedule 13G for Catheter Precision, Inc. (VTAK)?
What addresses are listed for Catheter Precision, Inc. (VTAK) and SEG JETS SPV I, LLC?
What class of securities in VTAK is reported in this Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.